All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $80,000.00 income · posted Oct 20, 2025

Official filing document

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

Alternatives to PAIN Act, IRA, innovation, health disparities, orphan drugs, 340B, opioid alternative medicines, SUPPORT Act reauthorization, awareness of rare kidney disorders

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.